Anne Tybjærg-Hansen

Anne Tybjærg-Hansen

Clinical Professor

Member of:

  • Clinical Biochemistry


Publication year:
All
1 - 10 out of 22Page size: 10
Sort by: 1st author
  1. Published

    Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease

    CHD Exome+ Consortium, C. E. C., CARDIoGRAM Exome Consortium, C. E. C. & Global Lipids Genetics Consortium, G. L. G. C., 11 Mar 2016, In: Science (New York, N.Y.). 351, 6278, p. 1166-71 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Increased Baseline C-Reactive Protein Concentrations Are Associated with Increased Risk of Infections: Results from 2 Large Danish Population Cohorts

    Zacho, J., Benfield, Thomas, Tybjærg-Hansen, Anne & Nordestgaard, Børge, Feb 2016, In: Clinical Chemistry. 62, 2, p. 335-42 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    SCARB1 Gene Variants Are Associated With the Phenotype of Combined High High-Density Lipoprotein Cholesterol and High Lipoprotein (a)

    Yang, X., Sethi, A. A., Yanek, L. R., Knapper, C., Nordestgaard, Børge, Tybjærg-Hansen, Anne, Becker, D. M., Mathias, R. A., Remaley, A. T. & Becker, L. C., Oct 2016, In: Circulation: Cardiovascular Genetics. 9, 5, p. 408-418 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    The Sialylation Pathway and Coronary Artery Disease

    Tybjærg-Hansen, Anne, 2 Jun 2016, In: New England Journal of Medicine. 374, 22, p. 2169-2171 3 p.

    Research output: Contribution to journal › Editorial › Research

  5. Published

    Using Human Genetics to Predict the Effects and Side Effects of Lipoprotein(a) Lowering Drugs

    Tybjærg-Hansen, Anne, Dec 2016, In: Journal of the American College of Cardiology. 68, 25, p. 2773-2775 3 p.

    Research output: Contribution to journal › Comment/debate › Research

  6. Published

    Using human genetics to predict the effects and side-effects of drugs

    Stender, S. & Tybjærg-Hansen, Anne, Apr 2016, In: Current Opinion in Lipidology. 27, 2, p. 105-111 7 p.

    Research output: Contribution to journal › Review › Research › peer-review

  7. Published

    Data on plasma levels of apolipoprotein E, correlations with lipids and lipoproteins stratified by APOE genotype, and risk of ischemic heart disease

    Rasmussen, K. L., Tybjærg-Hansen, Anne, Nordestgaard, Børge & Frikke-Schmidt, Ruth, Mar 2016, In: Data in Brief. 6, p. 923-932 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Plasma levels of apolipoprotein E and risk of ischemic heart disease in the general population

    Rasmussen, K. L., Tybjærg-Hansen, Anne, Nordestgaard, Børge & Frikke-Schmidt, Ruth, Mar 2016, In: Atherosclerosis. 246, p. 63-70 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Genetics of Coronary Artery Disease

    McPherson, R. & Tybjærg-Hansen, Anne, 18 Feb 2016, In: Circulation Research. 118, 4, p. 564-578 15 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Components of the Metabolic Syndrome and Risk of Type 2 Diabetes

    Marott, S. C. W., Nordestgaard, Børge, Tybjærg-Hansen, Anne & Benn, Marianne, Aug 2016, In: The Journal of clinical endocrinology and metabolism. 101, 8, p. 3212-3221 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 Next

ID: 924951